The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. [electronic resource]
- Expert opinion on therapeutic targets Nov 2008
- 1347-66 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review